Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab

Tocilizumab (TCZ) and Dexamethasone are used for the treatment of critically ill COVID-19 patients. We compared the short-term survival of critically ill COVID-19 patients treated with either TCZ or Dexamethasone. 109 critically ill COVID-19 patients randomly assigned to either TCZ therapy (46 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashad, Alaa, Mousa, Sherif, Nafady-Hego, Hanaa, Nafady, Asmaa, Elgendy, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065149/
https://www.ncbi.nlm.nih.gov/pubmed/33893337
http://dx.doi.org/10.1038/s41598-021-88086-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065149/
https://www.ncbi.nlm.nih.gov/pubmed/33893337
http://dx.doi.org/10.1038/s41598-021-88086-x

Ejemplares similares